1 products were found matching "1638338-43-8"!

No results were found for the filter!
Navicixizumab
Navicixizumab

Item number: TGM-T76871-5mg

Description: Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody that can be combined with Paclitaxel for cancer research, particularly in studies of ovarian, primary peritoneal, or fallopian tube cancer [1] [2] [3].
Application: Targets delta (DLL)
CAS 1638338-43-8
Please request pricing for this article.
Review